EligibleTrials

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

Recruiting · NCT03351842 · Interventional (participants receive a specific treatment) · Lead sponsor: Shanghai Pulmonary Hospital, Shanghai, China

View the official record on ClinicalTrials.gov →
Lung cancer

Interventions studied

Undergo surgerycis Platinum/Carboplatin, Pemetrexed Disodium

What this trial is about

Randomized phase II trial aims to compare surgery with or without adjuvant chemotherapy in treating patients who are pathologically diagnosed as stage I lung adenocarcinoma with micropapillary component no less than 20%.

Who can take part

Age range
19 Years to 70 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.